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Objectives This study investigated the feasibility of noninvasive renal sympathetic denervation (RSD) by using the novel ap-
proach of extracorporeal high-intensity focused ultrasound (HIFU).
Background Catheter-based RSD has achieved promising clinical outcomes.
Methods Under the guidance of Doppler flow imaging, therapeutic ablations (250 W  2 s) were performed by using ex-
tracorporeal HIFU on the bilateral renal nerves (36.3  2.8 HIFU emissions in each animal) in a mean 27.4-min
procedure in 18 healthy canines of the ablation group. Similar procedures without acoustic energy treatment
were conducted in 5 canines of the sham group. The animals were killed on day 6 or 28. Blood pressure (BP),
plasma noradrenaline (NA) level, and renal function were determined on days 0, 6, and 28. Pathological exami-
nations were performed on all retrieved samples.
Results All of the animals survived the treatment. After ablation, BP and NA significantly decreased compared with the
baseline values (BP changed 15.9/13.6 mmHg, NA changed 55.4% [p  0.001] 28 days after ablation])
and compared with the sham group on days 6 and 28. Ablation lesions around the renal artery adventitia were
observed on day 6. A histological examination revealed the disruption of nerve fibers, necrosis of Schwann cells
and neurons, and apparent denervation on day 28. No procedure-related complications were observed.
Conclusions Effective RSD was successfully achieved by using the extracorporeal HIFU method in canines. Thus, noninvasive
HIFU may be further explored as an important and novel strategy for RSD. (J Am Coll Cardiol 2013;61:
2185–92) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.02.050It is estimated that 1 billion individuals worldwide suffer
from hypertension, and hypertension-related complications
are recognized as the major cause of morbidity and mortality
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2013, accepted February 14, 2013.(1). Recently, a catheter-based strategy for renal sympa-
thetic denervation (RSD) was developed for the manage-
ment of drug-resistant hypertension, and it has achieved
encouraging clinical outcomes (2). The therapeutic benefits
of RSD have also been shown for those diseases associated
with sympathetic overactivity, such as insulin resistance,
arrhythmia, and heart failure (3,4). However, intervention-
related complications can occasionally occur. In addition,
vascular wall injury has been observed in a pre-clinical
model (5), and hemodynamic stenosis has been found in
clinical case reports, possibly due to related complications
(6). Many new devices are currently under investigation,
such as chemical renal denervation using a drug delivery
approach with a sidehole balloon catheter, which may help
to reduce the potential damage to the artery wall (7).
High-intensity focused ultrasound (HIFU) has been used
to noninvasively ablate tissue by extracorporeally delivering
focused acoustic energy. This technique is considered the
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Renal Sympathetic Denervation by High-Intensity Ultrasound May 28, 2013:2185–92ideal source of energy, especially
for the ablation of deep solid tissue
(8). It has also been clinically used
to treat uterus, kidney, and liver
tumors (9,10). In addition, the
application of HIFU has been
expanded significantly in recent
years (11,12).
To the best of our knowl-
edge, few studies have reported
the use of noninvasive HIFU
for RSD. The current study was
designed to explore the possible
use of this new technique for
RSD in a canine model by in-
estigating the feasibility and safety associated with this
rocedure.
ethods
IFU system for RSD. The HIFU tumor therapeutic
ystem (Model-JC200, certified by the European Union,
hongqing Haifu Technology Co. Ltd., Chongqing,
hina) was used. The therapeutic focused ultrasound beam
as produced by a 220-mm spherically curved therapeutic
ransducer with focal length of 132 mm. The physical focal
egion was ellipsoid and 2  2  6 mm3. The operating
frequency was 0.98 MHz (corresponding to 1.58-mm wave-
length). The acoustic power of the therapeutic transducer
ranged from 33 to 550 W, with an acoustic intensity at focus
from 467 to 7,785 W/cm2 under a degassed water acoustic
nvironment. A diagnostic probe was aligned coaxially to
he therapeutic transducer to locate the target tissues. By
djusting the transducer in 3 dimensions, the focus could be
oved 1 mm by 1 mm to target the renal artery.
nimal preparation. The experimental protocol was ap-
roved by the Institutional Ethics Committee of
hongqing Medical University. The use and care of the
nimals were in compliance with the U.S. National
nstitutes of Health Guide for Care and Use of Labora-
ory Animals.
Twenty-three healthy mongrel canines (15 to 20 kg,
urchased through the Experimental Animal Care Center
f Chongqing Medical University) of either sex were dis-
ributed randomly into an ablation group (n  18) and a
ham group (n  5). All of the canines were anesthetized
ith 3% pentobarbital sodium (30 mg/kg) intraperitone-
lly. The abdominal fur along the acoustic path was
emoved, and the skin was degreased with 75% alcohol
nd suctioned for degassing. The right femoral artery was
unctured, and a syringe attached to a pressotransducer
Model YPJ01, Chengdu Instrument Factory, Chengdu,
hina) temporarily for every invasive blood pressure (BP)
easurement. BP was recoded with a RM6240 Physiol-
gy Signal Collection Processing System (Chengdu In-
Abbreviations
and Acronyms
BP  blood pressure
BUN  blood urea nitrogen
CDFI  color Doppler flow
imaging
HIFU  high-intensity
focused ultrasound
NA  noradrenaline
Na  sodium
RSD  renal sympathetic
denervation
sCr  serum creatininetrument Factory) before ablation (defined as baseline). pt days 6 and 28 post-ablation, the follow-up study used
similar procedure to measure BP, which was recorded
0 min post-anesthesia.
IFU ablation procedure for RSD. In the ablation
roup, the left abdominal wall of each canine was immersed
n the therapeutic chamber filled with degassed water,
hich provided acoustic coupling between the transducer
nd skin (13). Color Doppler flow imaging (CDFI) on the
ong-axis view of the left renal artery was obtained by
djusting the relative positions of the transducer and animal
Fig. 1A). Using CDFI as a guide, the foci of the extracor-
oreal HIFU were set on the zygomorphic wall at the
Figure 1 Schematic of RSD With HIFU; Ablation Foci
Were Set and Ablated by CDFI Guidance
(A) The focus of high-intensity focused ultrasound (HIFU) energy (green spot)
was set to cross the wall of the renal artery. Green spot: the focal point of the
HIFU energy; black arrow: renal artery. RSD  renal sympathetic denervation.
(B) Ablation foci (green spots) were targeted by 3-dimensional movement of
the transducer guided by color Doppler flow imaging (CDFI). The locations on
the renal artery that were ablated appear as red spots. White arrows  kid-
ney; yellow arrow  renal artery.roximal, middle, and distal right renal artery, respectively.
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May 28, 2013:2185–92 Renal Sympathetic Denervation by High-Intensity UltrasoundTherapeutic ablations (250 W  2 s) were performed at
ach set of foci. A total of 6 emissions of acoustic power
ere delivered when every segment of the renal artery was
isible on an ultrasonographic view (Fig. 1B). The thera-
eutic transducer was moved 2 mm dorsally or ventrally to
nitiate the viewing of the next set of ablations. In each
isual field, the focus locations and power emissions were
uided by using CDFI. For example, there were 2 emissions
f acoustic delivery if the ultrasonographic view could only
rovide the proximal segment, and the deliveries of acoustic
nergy were not finished until the CDFI of the renal artery
isappeared. The same procedure was subsequently per-
ormed on the right renal artery. In the sham group, 5
anines underwent a similar procedure without the delivery
f acoustic energy. The procedure time, defined as the
uration when the animal was immersed in the therapeutic
hamber until the bilateral renal nerve had been ablated, was
ecorded for every animal.
ost-ablation procedure. All animals received standard
are. In the ablation group, the canines were killed on day 6
n  10) or day 28 (n  8) post-ablation by intravenous
njection of 10% potassium chloride after BP was measured
nvasively. The tissues along the acoustic path and near the
oci, including the abdominal wall, kidney, spleen, ureters,
ntestinal tract, liver, and target renal artery, were retrieved
or gross and histological examination. In the sham group,
P was also measured on days 6 and 28, and the histological
xamination was performed on day 28.
enal function and sympathetic activity detection. The
lasma noradrenaline (NA) concentration was measured by
sing a commercially available radioimmunoassay kit (Labor
iagnostika Nord GmbH & Co. KG, Nordhorn, Ger-
any) (14). Blood urea nitrogen (BUN), serum creatinine
sCr), and serum sodium (Na) were measured by using a
tandard procedure before ablation and on days 6 and 28.
tatistical analysis. Changes in BP, NA, BUN, sCr, and
avalues were analyzed from baseline to 6 or 28 days by
sing analysis of variance models for completely randomized
nd for repeated measure designs. p  0.05 was conside-
ed statistically significant. The data are presented as the
ean  SD or percent change. All statistical analyses were
erformed by using SAS version 9.3 (SAS Institute Inc.,
ary, North Carolina).
esults
verall procedural considerations. CDFI of the targeted
enal artery was acquired in all experimental canines. In this
tudy, 3 to 5 CDFI-guided ultrasonographic views of the
enal arteries were obtained in each unilateral renal artery,
lthough some views only showed segmental vessels. The
otal mean HIFU ablation was 36.3  2.8 emissions for the
SD of each pair of renal arteries, and the procedure time
as 27.4  3.7 min. oP measurement. On days 6 and 28 post-ablation, systolic
P (12.3 and 15.9 mm Hg on days 6 and 28; both p 0.001)
nd diastolic BP (11.6 and 13.6 mm Hg on days 6 and 28;
oth p  0.001) significantly decreased relative to the
ndividual baseline BP (Fig. 2A). Similarly, after ablation,
he BP in the ablation group was significantly lower than
hat of the sham group on both days.
In the sham group, at baseline and the 6- and 28-day
ollow-up, BP had not significantly changed (Table 1).
enal functions and sympathetic activity detection. On
ay 6 post-ablation, NA was reduced by 50.1% (p 0.001),
ut BUN, sCr, and Na were not significantly different
rom baseline levels. However, both NA (55.4%; p 0.001)
nd Na (4.5%; p  0.007) were reduced on day 28
post-ablation; BUN and sCr were not significantly different
from baseline (Fig. 2B). Meanwhile, NA and Na in the
blation group were significantly lower than that of the
ham group on day 28.
In the sham group, at baseline and the 6- and 28-day
ollow-ups, there were no significant differences among NA,
UN, sCr, or Na(Table 1).
ross and histological evaluation. In the ablation group,
gross examination revealed the presence of several hem-
rrhagic spots on the fatty tissue around the target renal
rteries in a diffused or clustered distribution pattern on day
. After removing the fatty tissue layer, ablation lesions were
lso found on the renal artery adventitia, and some lesions
ere clustered around the nerve fibers (Fig. 3A). On day 28,
he slightly yellow fatty tissue was adhered to the target
egions, although the lesions of the fatty tissue were gone
Fig. 3B).
A histological evaluation showed the vacuolar change of
he target nerve fibers and a change of the interstitium to a
ildly myxoid phenotype on day 6. The nuclei of the
chwann cells were darkly stained and exhibited pyknosis or
aryorrhexis, or were even absent (Figs. 4A and 4B). The
istal regions of the target lesions showed ganglion-like
egeneration, swelling of the perikaryon, eosinophilic en-
ichment, and, in some cases, the disappearance of Nissl
odies.
On day 28, the target nerve fibers appeared shrunken and
acuolated. Necrosis of the Schwann cells was also observed
round the targeted area. The myxoid change of the nerve
bers was more apparent than on day 6 (Figs. 4C and 4D).
n the sham group, the histological findings remained
nchanged.
afety considerations. The vital signs of all canines were
ormal during the procedure and post-ablation. All of the
anines survived the treatment until they were killed. The
ross and histological evaluations did not reveal significant
njuries along the acoustic path, including the skin, liver,
pleen, kidney, ureters, intestinal tract, and the tissue
round the target region.
The targeted renal arteries were smooth and had an intact
ascular wall and endothelium. The ablation lesions were
nly found on the adventitia and immediately surrounding
2188 Wang et al. JACC Vol. 61, No. 21, 2013
Renal Sympathetic Denervation by High-Intensity Ultrasound May 28, 2013:2185–92the fatty tissue. Bleeding spots, ulcers, and thrombi were not
observed on the targeted renal arteries. In addition, histo-
logical examination showed an intact vascular structure with
an intact endothelium and vascular smooth muscle cells. No
evidence of inflammatory cell infiltration, hyperplasia, or
stenosis was observed 28 days later.
Discussion
The HIFU technique is a promising strategy for noninvasive
deep tissue ablation due to its ability to penetrate and target
tissues of interest. The acoustic energy can be delivered to
the target region inside the body for therapeutic ablation
without significant tissue injury along the path of the
acoustic beam and with acceptable targeting accuracy in
clinic practice (10,15). In the current study, noninvasive
RSD ablation was achieved in every animal by using a
Figure 2 Changes in SBP and DBP on Days 6 and 28 After RSD
Days 6 and 28 After Ablation
(A) Blood pressure (BP) was significantly lower compared with baseline values on
BP in the sham group. DBP  diastolic BP; RSD  renal sympathetic denervation;
lower on days 6 and 28, and sodium (Na) was lower on day 28 post-ablation com
NA, blood urea nitrogen (BUN), serum creatinine (sCr), and Naat 6 and 28 daysclinically approved HIFU apparatus. After properly prepar-ing the skin by degreasing and degassing, the energy can be
more effectively delivered into the target tissues, thus
reducing the energy loss and possible tissue injury along the
acoustic path. On day 28 post-ablation, both BP and NA
were significantly lower than the baseline and the sham
group values. Hyperplasia and stenosis of the renal arteries
were not found, whereas the disruption of the renal nerve
remained, and the myxoid change and shrinkage of renal
nerve fibers were more significant, which suggests the RSD
persisted. The sham group served to control for factors
related to HIFU that could interfere with the results. The
results from the sham group demonstrate that our nonin-
vasive approach had little impact on BP or NA.
With the guidance of CDFI, extracorporeal HIFU acous-
tic energy can easily be targeted to the renal artery. In our
dual renal nerve ablation, a mean of 36.3 acoustic emissions
were delivered, but the cumulative duration was only ap-
rcent Changes in NA, BUN, sCr, and Na on
and 28 post-ablation in the ablation group; there was no significant change in
systolic BP. (B) In the ablation group, noradrenaline (NA) was significantly
with baseline values, respectively. There were no significant differences among
up in the sham group.; Pe
days 6
SBP 
pared
follow-proximately 73 s; therefore, the entire procedure duration
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May 28, 2013:2185–92 Renal Sympathetic Denervation by High-Intensity Ultrasoundcan generally be limited to 0.5 h. Although the size of a
single lesion created by HIFU ablation is relatively small,
increasing the number of ablations in the renal artery
adventitia by using different viewing segments should im-
prove the safety and efficiency of RSD.
It remains controversial whether RSD affects the BP of
normotensive animals. Some studies indicated that BP was
reduced compared with baseline (16,17). In the current
study, BP was significantly decreased in a large, healthy,
aggressive animal model, which correlated with a remark-
able decrease in plasma NA, suggesting that the sympathetic
activity may be at least partially reduced by HIFU ablation.
The extent of the decrease in diastolic BP was similar to the
decrease in systolic BP. Interestingly, our results differ from
those reported by some previous studies, which showed that
systolic BP decreased markedly more than diastolic BP (2).
ne possible reason for this difference may be indirectly
ttributed to the decreased blood volume and Na levels
aused by the large reduction of NA in our normal BP
odel after HIFU ablation. Furthermore, our results
Figure 3 Gross Examination of the Ablation Lesion on
Days 6 and 28
(A) The ablation lesions (yellow arrows) were also found on the adventitia of
the renal artery, with some lesions clustered around the nerve fibers (green
arrows). (B) The renal sympathetic denervation (RSD) lesions disappeared,
and slightly yellow fatty tissue was observed in the proximal, middle, and distal
regions of the renal artery (yellow arrows).suggest that the HIFU-mediated RSD may be permanentBP T
V S D N N B sC
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lu B
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Renal Sympathetic Denervation by High-Intensity Ultrasound May 28, 2013:2185–92because the myxoid change and shrinkage of the targeted
renal nerve fibers were still present 28 days post-ablation.
Although HIFU acoustic energy targeted whole layers of
the renal arteries, a pathological evaluation revealed that
both the vascular wall and the endothelial layer remained
intact. The therapeutically ablated regions were restricted to
the vascular adventitia and the area immediately surround-
ing the fatty tissue. This phenomenon may be explained by
the possible cooling effect of the rapidly circulating blood-
stream within the targeted renal arteries and the absence of
any catheter to limit the flow of the renal artery. This result
is consistent with a previous report that blood vessels are
more resistant to acoustic energy (18). On the other hand,
ultrasound-inhibited nerve conduction block for pain man-
agement and treatment of spasticity has been actively
investigated for nearly 50 years; this nerve conduction block
can been achieved with lower acoustic energy, suggesting
that the nerve fibers may be more sensitive to HIFU energy
(19,20). Although the gross and histological appearance of
Figure 4 Histological Examination of the Target Nerve Bundles
(A) Day 6 after RSD (H&E  100). The renal artery with an intact wall and endoth
increased due to the edema and pyknosis of renal nerve fibers. (B) Day 6 after RS
karyorrhexis, or even disappearance. The mild myxoid change of interstitium can b
thelium was surrounded by the damaged nerve fibers. The nerve fibers were shrun
28 after RSD. (D) Day 28 after RSD (H&E  400). The myxoid change in the appe
toxylin and eosin stain; RSD  renal sympathetic denervation.the nerve fibers around the ablation target area was normal,pathological examination revealed that the nerve fiber struc-
ture was significantly damaged and disrupted 28 days
post-ablation. This phenomenon suggests that acoustic
energy may selectively target the nerve fibers at a lower
acoustic intensity level.
In a study of patients with uterine fibroids undergoing
HIFU ablation (21) in which the ablative depth was similar
to our study, although the incidence of pain was frequent,
the pain was described as slight to moderate. With lower
energy intensity and very short duration of acoustic delivery,
the authors presumed that the pain experienced by patients
undergoing HIFU ablation is acceptable.
High acoustic intensity and long-time acoustic energy
delivery induced skin toxicity (8/30) and edema (8/30) at
the treatment site when HIFU was used for tumor ablation,
although most of these adverse effects were slight (10). In
our study, the acoustic intensity and exposure were signifi-
cantly lower than that used in previous studies, and the
cumulative acoustic energy used in this study was approxi-
ays 6 and 28 After RSD
surrounded by the damaged nerve fibers. The spaces between the perineurium
E  400). The nuclei of Schwann cells are darkly stained and exhibit pyknosis,
n. (C) Day 28 after RSD (H&E  100). The renal artery with intact wall and endo-
d more vacuolated, and the Schwann cells appeared to be more necrotic on day
e of the nerve fibers was more distinct on day 28 than on day 6. H&E  hema-on D
elium
D (H&
e see
ken an
arancmately 3% of that previously used for clinical tumor ablation
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May 28, 2013:2185–92 Renal Sympathetic Denervation by High-Intensity Ultrasound(i.e., 250 vs. 399.5 W and 72 vs. 1,200 s) (10,21). In
addition, our total procedure time was significantly shorter.
Thus, the lower energy input delivered by HIFU may
reduce the discomfort and damage caused by the procedure,
and this further supports the safety claims of its possible use
in RSD in clinical settings.
On the basis of the results of the gross and microscopic
examinations, we found no evidence of significant injuries
along the acoustic transmission path, such as in the abdom-
inal wall, kidney, and tissues around the target renal arteries.
Nonetheless, it is conceivable that mild injuries occurred
along the path but quickly healed because the acoustic
intensity within these tissues was far lower than that at the
focal points.
Unlike the catheter-based strategy, the HIFU-mediated
RSD technique can be performed relatively independently
of anatomic variations in renal arteries. Thus, this technique
may be more suitable for certain conditions, such as
bifurcated renal arteries and renal arteries that are smaller
and shorter than normal (22). In contrast to the catheter-
based strategy, the HIFU technique uses ultrasound
without X-irradiation as a guide, which helps avoid
radiation exposure to both patients and operators. Fur-
thermore, although the therapeutic region of a single
ablation is relatively small, multiple ablation points may
be combined to achieve a desirable RSD for individual
patients. Mild RSD may be more suitable for individuals
with common hypertension and is not limited to those
with drug-resistant hypertension.
Study limitations. An invasive BP measurement under
anesthesia instead of in the conscious state was performed in
this study due to the technical difficulties of the latter. We
observed a possible change in BP measured in the conscious
state after HIFU, which needs further evaluation. The effect
of targeting RSD by using the HIFU technique depended
on the acoustic window and required CDFI guidance.
Therefore, this new technique may be not suitable for obese
patients or patients with emphysema. As an alternative, it
may be possible to use HIFU guided by magnetic resonance
imaging. Furthermore, a long-term follow-up study is
necessary to fully evaluate the efficacy and safety of the
HIFU strategy. A clinical trial may provide the most
valuable information.
Conclusions
Under CDFI guidance, RSD was achieved in a noninva-
sive manner in normotensive canines by using the extra-
corporeal HIFU technique without significant morbidity
or mortality. This new strategy may provide an alterna-
tive approach for the clinical treatment of drug-resistant
hypertension and other conditions associated with sym-
pathetic overactivity.Acknowledgments
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